Cytogenetics is a branch of genetics that studies the structure, function, and evolution of chromosomes. Chromosomes are genetic materials that are present in tissues and cells. They have different structures and banding patterns. Cytogenetic maps are used to arrange all the chromosomes based on their banding patterns. Any change in the banding pattern of chromosomes depicts abnormalities or genetic disorders such as sickle cell anemia, cancer, Down syndrome, Turner syndrome, and others. Various techniques are used for cytogenetics such as karyotyping, comparative genomic hybridization (CGH), and fluorescent in situ hybridization (FISH). The biological application of cytogenetics includes the detection of numerical and structural chromosomal abnormalities, analysis of cancer, genetic testing, study of genotoxicity, prenatal diagnosis, and others.
The cytogenetics market is primarily driven by an increase in the prevalence of genetic disorders and cancer. For instance, according to WHO, cancer is the second leading cause of death worldwide and cause an estimated 9.6 million deaths in 2018. Low- and middle-income countries reported approximately 70% deaths due to the disease. In addition, rise in health care spending, increase in the prevelance of chronic diseases, and a favorable reimbursement scenario are expected to boost the expansion of the global cytogenetics market in the coming years. Furthermore, existing market players deploy advanced techniques and strategies to come up with novel ways of cytogenetic analysis. This is expected to drive the market in the near future. However, the cytogenetic procedure is time consuming and involves high cost of analysis. These factors are expected to restrain the market during the forecast period. Nevertheless, emerging nations such as China and India are expected to provide attractive market opportunities to the market during the forecast period.
The global cytogenetics market can be segmented based on product, technique, application, end-user, and region. In terms of product, the market can be classified into test kits, media and reagents, probes, consumables, instruments, and software & services. Based on technique, the market can be categorized into fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), karyotyping, immunohistochemistry, and others. The comparative genomic hybridization segment is expected to expand at a rapid CAGR during the forecast period, owing to an increase in the transition from FISH to array-based CGH. The comparative genomic hybridization segment can be further divided into array-based CGH and standard CGH. In terms of application, the market can be segmented into cancer, genetic disorders, personalized medicines, and others. Based on end-user, the market can be categorized into biotechnology & pharmaceutical companies, research laboratories, academic research institutes, and others.
In terms of region, the global cytogenetics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the cytogenetics market in 2017 with a prominent market share. This is owing to technological advancements and significant adoption of technologically advanced products, presence of a large number of manufacturers in the U.S., and high health care spending in the region. According to the National Cancer Institute, in 2016, there were an estimated 15.5 million cancer survivors in the U.S.. The number of cancer survivors is expected to increase to 20.3 million by 2026. Asia Pacific and Latin America are expected to be lucrative regions of the cytogenetics market due to the expansion of economies of countries in these regions, rise in population, increase in the incidence of cancer, and rise in awareness about and adoption of cytogenetic analysis among people in the regions.
Key players operating in the global cytogenetics market include Applied Spectral Imaging, Inc., Abbott Laboratories, Empire Genomics, LLC., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer Inc., Irvine Scientific., OPKO Health, Inc. (GeneDx.), Thermo Fisher Scientific, Inc., and Sysmex Corporation (Oxford Gene Technology).
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.